A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
Clinical trial NCT05567354 · COMPLETED
Trial details
- NCT number
- NCT05567354
- Sponsor
- Ensysce Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2022-08-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.